Financhill
Back

Vistagen Therapeutics Stock Predictions

10 Best Stocks to Own in 2025

Get your copy now FREE!
Sell
31

VTGN
Vistagen Therapeutics

Last Price:
$2.54
Seasonality Move:
-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

10 stocks to buy for the next leg of this rally

Get the full list here FREE

Vistagen Therapeutics Stock Forecast

  • Is Vistagen Therapeutics Stock Undervalued?
    The current Vistagen Therapeutics [VTGN] share price is $2.55. The Score for VTGN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • VTGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vistagen Therapeutics Stock Go Up Next Year?

Data Unavailable

Vistagen Therapeutics Stock Rating

Data Unavailable

Vistagen Therapeutics Stock Price History

Is VTGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTGN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vistagen.com

52-Week Data

52-Week High:
4.21
52-Week Low:
1.90

Prediction Charts

Market Cap:
73.6M
Price in USD:
2.55
Volume:
142.6K
Beta:
-0.39

Technical Analysis

SMA50:
2.36
SMA100:
2.61
SMA200:
2.80
52-Wk Change:
-35.61%

Stock Predictions

  • Is Vistagen Therapeutics stock public?
    Yes, Vistagen Therapeutics is a publicly traded company.
  • What is the Vistagen Therapeutics stock quote today?
    The Vistagen Therapeutics stock price is 2.55 USD today.
  • How to buy Vistagen Therapeutics stock online?
    You can buy Vistagen Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-9 2.22 2.24 2.34 2.22
May-12 2.30 2.32 2.38 2.26
May-13 2.32 2.37 2.37 2.25
May-14 2.35 2.26 2.39 2.26
May-15 2.30 2.30 2.34 2.20
May-16 2.34 2.46 2.55 2.31
May-19 2.44 2.55 2.55 2.40
May-20 2.57 2.63 2.66 2.44
May-21 2.60 2.43 2.60 2.40
May-22 2.47 2.43 2.47 2.39
May-23 2.40 2.41 2.43 2.35
May-27 2.44 2.43 2.48 2.39
May-28 2.44 2.53 2.57 2.40
May-29 2.55 2.55 2.63 2.51

Vistagen Therapeutics Earnings

Data Unavailable

Vistagen Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.40 per share.

* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.